ADRB2 and Parkinson disease: With regards to β2AR antagonists and PD, there are reports that suggest a link to increased risk37,38, those that show no association46, and those that observed an association until adjusting for sustained exposure, a 5-year lag between exposure and PD diagnosis, or a specific antagonist propranolol35,36,39,40.